ArticleExperimental and therapeutic medicine2017
EGFR and Cortactin: Markers for potential double target therapy in oral squamous cell carcinoma.
Oliver Bissinger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it